Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
14172%Stock Based Compensation Margin
VS
Market
Sector
Industry
History
$ 1.86Close
$ 1.76 - $ 10.48 52-Week Range
Ticker Information
Ticker
INMBCompany Name
INMUNE BIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQINMUNE BIO INC - Stock Based Compensation Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
INMB - SB Comp % Historical data
| Date | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
|---|---|---|---|
| 6/30/2025 | $ 50K | $ 7.09M | 14172% |
| 3/31/2025 | $ 50K | $ 7.9M | 15804% |
| 12/31/2024 | $ 14K | $ 7.61M | 54321.43% |
| 9/30/2024 | $ 42K | $ 7.73M | 18397.62% |
| 6/30/2024 | $ 85K | $ 7.9M | 9290.59% |
| 3/31/2024 | $ 131K | $ 7.41M | 5656.49% |
| 12/31/2023 | $ 155K | $ 7.37M | 4753.55% |
| 9/30/2023 | $ 224K | $ 7.28M | 3248.66% |
| 6/30/2023 | $ 279K | $ 7.33M | 2626.16% |
| 3/31/2023 | $ 249K | $ 7.35M | 2951.81% |
Key Performance Insights, Last 5 Years
- INMUNE BIO INC's latest trailing twelve months (TTM) SB Comp % stands at 0%.
- Over the past 5 years, INMUNE BIO INC's average SB Comp % has been 13002.84%.
- The median SB Comp % for INMUNE BIO INC during this period was 5656.49%
- INMUNE BIO INC reached its highest SB Comp % over the past 5 years at 54321.43%.
- The lowest SB Comp % recorded by INMUNE BIO INC in the same timeframe 1564.32%
INMUNE BIO INC's SB Comp % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp % Benchmarks
Similar metrics to SB Comp %:
- Stock Based Compensation - [Cash Flow Statement] Stock Based Compensation, also called Share Based Compensation or Equity Compensation, is a method of paying directors, executives and employees with equity in the business. As non-cash expense, this element is added back when calculating net cash generated by operating activities [NCFO].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
Definition of Stock Based Compensation Margin
[Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].SB Comp. / Revenues
(=) SB Comp % SB Comp % for INMUNE BIO INC is calculated as follows: SB Comp. [ $ 3.58M ] / Revenues [ $ 0 ]
(=) SB Comp % [ 0% ] INMB - Stock Based Compensation Margin, Last 5 years
1564.32%
Minimum
Sep 30, 2022
54321.43%
Maximum
Dec 31, 2024
13002.84%
Average
5656.49%
Median
SB Comp % Benchmark AnalysisMarket
The chart above depicts the distribution of SB Comp % for companies in the Total Stock Market. The average SB Comp % of the companies is 1.72% with a standard deviation of 1.9%.
The following table provides additional summary stats:
SB Comp % in the Market:
| filtered constituents | 2.98K |
|---|---|
| min | -3.97% |
| max | 8.43% |
| average | 1.72% |
| median | 1.04% |
| std | 1.9% |